Myriad将以超2.1亿美元全现金交易向Labcorp出售产前健康业务（MYGN:NASDAQ）
· seekingalpha.com
Myriad Genetics（MYGN）股价上涨，公司以超过2.1亿美元的全现金交易将其产前健康检测业务出售给Labcorp。在此阅读更多。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...